SLC2A3 functions as a tumor promoter and accelerates aerobic glycolysis in gastric cancer cells, and it potentially contributes to the M2 subtype transition of infiltrating macrophages in the microenvironment of gastric cancer. The gene discussed is SLC2A3; the disease is neoplasm.